Brackmann Christoph bought NVCR
March 4, 2025 · Form 4 insider transaction
Brackmann Christoph bought 54,975 shares of NovoCure Limited at $18.19 per share, a transaction worth $1000.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
54,975
Price
$18.19
Total value
$1000.0K
InsiderBrackmann Christoph
RoleOfficer
CompanyNovoCure Limited (NVCR)
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateMarch 4, 2025
Filing dateMarch 6, 2025
Shares owned after121,150
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.